|
Issue with Area Drop During N-Nitroso Dorzolamide Method Setup
|
|
3
|
173
|
December 10, 2025
|
|
N-nitroso-n-desmethyl xanomeline
|
|
0
|
91
|
December 10, 2025
|
|
Levetiracetam_Presence of Nitrosamines
|
|
0
|
114
|
December 9, 2025
|
|
NDSRI in Pyrathiazine theocolate
|
|
3
|
280
|
December 5, 2025
|
|
EMA - Appendix 1 - Update
|
|
70
|
6888
|
December 5, 2025
|
|
WHO Updates on Nitrosamine Impurities
|
|
3
|
591
|
December 3, 2025
|
|
I found a recent review paper on nitrsoamine risk assessment in pharmaceuticals
|
|
6
|
682
|
December 3, 2025
|
|
Nitrites in Excipients
|
|
7
|
428
|
November 28, 2025
|
|
Role of Carbonyl Compounds for N-Nitrosamine Formation during Nitrosation: Kinetics and Mechanisms
|
|
1
|
523
|
November 27, 2025
|
|
FDA Approves Reformulated Ranitidine - Nitrosamine Impurities - NDMA
|
|
3
|
390
|
November 27, 2025
|
|
đĄ-đĄđśđđżđźđđŽđşđśđťđ˛ đđźđżđşđŽđđśđźđť đśđť đŁđľđŽđżđşđŽđ°đ˛đđđśđ°đŽđš đđżđđ´ đŁđżđźđąđđ°đđ: đđ˛đđ˛đšđźđ˝đşđ˛đťđ đŽđťđą đŠđŽđšđśđąđŽđđśđźđť đźđł đŽ đđśđŽđđ˛đą, đđźđťđđ˛đżđđŽđđśđđ˛, đŁđżđ˛đąđśđ°đđśđđ˛ đ đźđąđ˛đš
|
|
1
|
304
|
November 26, 2025
|
|
N-Nitrosamine Formation in Pharmaceutical Drug Products: Development and Validation of a Biased, Conservative, Predictive Model-Pub
|
|
4
|
423
|
November 24, 2025
|
|
In Vitro Metabolism Study of NDSRIs
|
|
3
|
259
|
November 20, 2025
|
|
đŻđľ Current Nitrosamine Landscape in Japan?
|
|
181
|
15880
|
November 19, 2025
|
|
Grenzwert fĂźr N-nitroso oxymetazoline
|
|
4
|
113
|
November 19, 2025
|
|
đŞđŹ Egypt (EDA) Public Consultation regarding the Guidelines for Nitrosamine Impurities
|
|
0
|
98
|
November 19, 2025
|
|
Studies addressing potential bioactivation and genotoxicity liabilities of the N-nitroso derivative of the antidepressant paroxetine-Pub
|
|
0
|
101
|
November 18, 2025
|
|
Nitrosamine Contamination in Pharmaceuticals: A Retrospective Regulatory Analysis of USFDA Recalls and Risk Mitigation Strategies (2018â2025)-Pub
|
|
0
|
210
|
November 18, 2025
|
|
N-Nitroso meglumine
|
|
18
|
1376
|
November 18, 2025
|
|
N-Nitroso-Desmethyl-tetracycline MOA development
|
|
1
|
146
|
November 18, 2025
|
|
N nitroso urapidil
|
|
0
|
78
|
November 18, 2025
|
|
FDA Announcement - Small Molecule Nitrosamines in Infusion Bags
|
|
12
|
2212
|
November 16, 2025
|
|
EMA - nitrosamines Leading Member State (LMS)
|
|
2
|
299
|
November 13, 2025
|
|
N-Nitroso-API calculation limit
|
|
9
|
735
|
November 13, 2025
|
|
FDA is serious about risk assessments!
|
|
3
|
591
|
November 11, 2025
|
|
Nitrosamine Control: From Risk Assessment to Analytical Testing with Emphasis on Sample Preparation and Phase-Appropriate Method Validation-Pub
|
|
0
|
295
|
November 8, 2025
|
|
N-nitrosamine occurrence in disinfected drinking water
|
|
0
|
235
|
November 5, 2025
|
|
FDA recalls blood pressure medicine over cancerous chemical
|
|
2
|
470
|
November 5, 2025
|
|
Nitrosamine Bootcamp in Indonesia & Korea
|
|
0
|
223
|
November 4, 2025
|
|
:australia: TGA - Latest Update to Nitrosamine Limits
|
|
10
|
2316
|
November 3, 2025
|